XBiotech Inc. (XBIT)
Total Valuation
XBiotech has a market cap or net worth of $248.17 million. The enterprise value is $48.15 million.
Market Cap | 248.17M |
Enterprise Value | 48.15M |
Important Dates
The last earnings date was Friday, March 15, 2024, after market close.
Earnings Date | Mar 15, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
XBiotech has 30.44 million shares outstanding. The number of shares has decreased by -0.00% in one year.
Shares Outstanding | 30.44M |
Shares Change (YoY) | -0.00% |
Shares Change (QoQ) | +0.02% |
Owned by Insiders (%) | 36.02% |
Owned by Institutions (%) | 15.15% |
Float | 17.09M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 1.13 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 33.07, with zero debt.
Current Ratio | 33.07 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -10.80% and return on invested capital (ROIC) is -17.14%.
Return on Equity (ROE) | -10.80% |
Return on Assets (ROA) | -10.50% |
Return on Capital (ROIC) | -17.14% |
Revenue Per Employee | n/a |
Profits Per Employee | -$299,476 |
Employee Count | 82 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, XBiotech has paid $244,000 in taxes.
Income Tax | 244,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +144.14% in the last 52 weeks. The beta is 1.43, so XBiotech's price volatility has been higher than the market average.
Beta (1Y) | 1.43 |
52-Week Price Change | +144.14% |
50-Day Moving Average | 6.00 |
200-Day Moving Average | 4.97 |
Relative Strength Index (RSI) | 78.27 |
Average Volume (30 Days) | 48,126 |
Short Selling Information
The latest short interest is 585,312, so 1.92% of the outstanding shares have been sold short.
Short Interest | 585,312 |
Short Previous Month | 537,487 |
Short % of Shares Out | 1.92% |
Short % of Float | 3.42% |
Short Ratio (days to cover) | 9.41 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -37.51M |
Pretax Income | -24.31M |
Net Income | -24.56M |
EBITDA | -22.57M |
EBIT | -24.31M |
Earnings Per Share (EPS) | -$0.81 |
Balance Sheet
The company has $200.02 million in cash and no debt, giving a net cash position of $200.02 million or $6.57 per share.
Cash & Cash Equivalents | 200.02M |
Total Debt | n/a |
Net Cash | 200.02M |
Net Cash Per Share | $6.57 |
Equity / Book Value | 218.85M |
Book Value Per Share | 7.19 |
Working Capital | 195.62M |
Cash Flow
In the last 12 months, operating cash flow was -$18.73 million and capital expenditures -$362,000, giving a free cash flow of -$19.09 million.
Operating Cash Flow | -18.73M |
Capital Expenditures | -362,000 |
Free Cash Flow | -19.09M |
FCF Per Share | -$0.63 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
XBiotech does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.00% |
Shareholder Yield | 0.00% |
Earnings Yield | -9.90% |
FCF Yield | -7.69% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |